Showing results (1-10 of 257) with videos related to
Sort By:
Pageof 26
Schweizerische Medizinische Wochenschrift|September 29, 2000
[HIV superinfection: myth or reality?]P L Vernazza, E Bernasconi, B HirschelAntiviral Therapy|March 21, 2000
Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort StudyO T Rutschmann, M Opravil, A Iten, et al.HIV Medicine|December 12, 2001
Combined therapy with saquinavir, ritonavir and stavudine in moderately to severely immunosuppressed HIV-infected protease inhibitor-naive patientsM Battegay, P L Vernazza, E Bernasconi, et al.The New England Journal of Medicine|April 29, 1999
Discontinuation of primary prophylaxis against Pneumocystis carinii pneumonia in HIV-1-infected adults treated with combination antiretroviral therapy. Swiss HIV Cohort StudyH Furrer, M Egger, M Opravil, et al.HIV Medicine|August 15, 2006
Prevalence of risk factors for cardiovascular disease in HIV-infected patients over time: the Swiss HIV Cohort StudyT R Glass, C Ungsedhapand, M Wolbers, et al.AIDS (London, England)|November 4, 2000
Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort StudyO T Rutschmann, P L Vernazza, H C Bucher, et al.AIDS (London, England)|June 19, 1998
A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort StudyO T Rutschmann, M Opravil, A Iten, et al.Swiss Medical Weekly|October 5, 2001
Antiretroviral prophylaxis for community exposure to the human immunodeficiency virus in Switzerland, 1997-2000E Bernasconi, J Jost, B Ledergerber, et al.Revue Medicale Suisse|January 24, 2009
[10 years of lipodystrophy--and so many uncertainties]A Calmy, E Bernasconi, C A Meier, et al.Therapeutische Umschau. Revue Therapeutique|June 27, 1998
[Sexual transmission of HIV: effect of potent antiretroviral therapy]P L VernazzaPageof 26